MedPath

Whole body vibration and balance training plus protein-rich nutrition to preserve postural control and muscle size during allogeneic haematopoietic cell transplantatio

Not Applicable
Conditions
all patients during allogeneic transplantation
C92
C93
D46
Myeloid leukaemia
Monocytic leukaemia
Myelodysplastic syndromes
Registration Number
DRKS00003492
Lead Sponsor
Medizinische Universitätsklinik Freiburg Abtl. Häm/Onk
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Recruiting withdrawn before recruiting started
Sex
All
Target Recruitment
200
Inclusion Criteria

All patients eligible for alloHCT
- Age: 18-80 years
- Signed informed consent

Exclusion Criteria

- Instable bone metastases

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Sway path of centre of pressure (postural control)<br><br>measure instrument:<br><br>Kraftmessplatte <br>(Kistler™ Kraftmessplatte, Kistler Instrumente GmbH Ostfildern, Deutschland) <br>patients will be tested at <br>the day of hospital admission T0<br>day + 30 after allogeneic transplantation T1<br>day + 100 after alloTX T2<br>
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath